Integrating Light-Based Techniques Improves Phototherapy for Cancer

Photoimmunotherapy targets cancer cells with microscopic, nano-engineered cancer drugs that are light-activated at the lesion site. Although the technology is increasingly used to treat metastatic cancer, tools to improve the effectiveness of photoimmunotherapy in gynecologic oncology have been lacking. Responses to treatment vary from person to person, and no method has existed to readily monitor whether the drugs are delivered effectively or have the desired therapeutic effect.